TY - JOUR
KW - COVID-19
KW - District of Columbia
KW - Humans
KW - Male
KW - Middle Aged
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Organizations, Nonprofit
KW - Pandemics
KW - SARS-CoV-2
KW - Telemedicine
KW - buprenorphine
KW - Harm Reduction
KW - medication-assisted treatment
KW - opioid use disorder
KW - telehealth
AU - E. J. Yeo
AU - H. Kralles
AU - D. Sternberg
AU - D. McCullough
AU - A. Nadanasabesan
AU - R. Mayo
AU - H. Akselrod
AU - J. Catalanotti
A1 - 
AD - HIPS Clinic, 906 H Street, NE, Washington, DC, 20002, USA. ellisjyeo@gmail.com.; Washington AIDS Partnership, 1701 Rhode Island Ave NW, Suite 03-108, Washington, DC, 20036, USA. ellisjyeo@gmail.com.; HIPS Clinic, 906 H Street, NE, Washington, DC, 20002, USA.; Washington AIDS Partnership, 1701 Rhode Island Ave NW, Suite 03-108, Washington, DC, 20036, USA.; HIPS Clinic, 906 H Street, NE, Washington, DC, 20002, USA.; HIPS Clinic, 906 H Street, NE, Washington, DC, 20002, USA.; HIPS Clinic, 906 H Street, NE, Washington, DC, 20002, USA.; HIPS Clinic, 906 H Street, NE, Washington, DC, 20002, USA.; Department of Medicine, The George Washington University, 2150 Pennsylvania Avenue, Washington, DC, 20037, USA.; Department of Medicine, The George Washington University, 2150 Pennsylvania Avenue, Washington, DC, 20037, USA.
BT - Harm reduction journal
C5 - Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
CP - 1
DO - 10.1186/s12954-021-00578-1
IS - 1
JF - Harm reduction journal
LA - eng
M1 - Journal Article
PB - . The Author(s)
PY - 2021
SN - 1477-7517; 1477-7517
SP - 127
T1 - Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C
T2 - Harm reduction journal
TI - Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C
U1 - Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U2 - 34886850
U3 - 10.1186/s12954-021-00578-1
VL - 18
VO - 1477-7517; 1477-7517
Y1 - 2021
Y2 - Dec 9
ER -